UK markets close in 3 minutes

Cnova N.V. (CNVAF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00000.0000 (0.00%)
As of 01:22PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close0.0000
Open0.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's range0.0000 - 0.0000
52-week range0.0000 - 3.0000
Volume1,000
Avg. volume0
Market cap6,904
Beta (5Y monthly)0.86
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Globe Newswire

    Cnova NV publishes 2023 Annual Financial Report

    CNOVA N.V.Publishes 2023 annual financial report AMSTERDAM – April 23 2024, 10 pm CET Cnova N.V. (Euronext Paris: CNV; ISIN: NL0010949392) (“Cnova” or the “Company”) has published its annual financial report for the year ended December 31, 2023 (the “report”). The report was filed with the Dutch Authority for the Financial Markets (Autoriteit Financiële Markten) and is available on the Company’s website, www.cnova.com. KPMG Accountants N.V. have issued an unqualified audit opinion in relation to

  • Globe Newswire

    Cnova N.V. : Acquisition of Predominant Control over Cnova

    Financial Restructuring of Casino Group Results in Change of Control over Cnova AMSTERDAM – April 2, 2024, 08:15 CET Cnova N.V. (Euronext Paris: CNV; ISIN: NL0010949392) (“Cnova”) hereby informs as follows: On behalf of France Retail Holdings S.à.r.l. (an entity ultimately controlled by Mr. Daniel Křetínský) ("FRH"), it is hereby announced that pursuant to the completion of the financial restructuring of the Casino group on March 27, 2024 (https://www.groupe-casino.fr/en/announcements/), FRH has

  • GlobeNewswire

    Cnova N.V. : Change to the Board of Directors

    CNOVA N.V.Change to the Board of Directors AMSTERDAM – March 28, 2024, 08:15 CET Cnova N.V. (Euronext Paris: CNV; ISIN: NL0010949392) (“Cnova” or the “Company”) today announces a change to its Board of Directors. The Company’s Chairman, non-executive director and member of the Nomination and Remuneration Committee, Mr. Jean-Yves Haagen, and Mrs. Josseline de Clausade, non-executive director, resigned their directorship as per March 27, 2024. The Company’s Board of Directors and management are mo